<?xml version="1.0" encoding="UTF-8"?>
<p>The need for well-defined core minimal datasets for emerging infectious diseases is not a new observation. A decade ago Sheila Bird and Jeremy Farrar [
 <xref rid="CIT0005" ref-type="bibr">5</xref>] noted the need to define a core minimal dataset for human cases of avian influenza A/H5N1, yet there remains no systematic examination of the completeness of the core data needed to design and conduct trials for high-priority pathogens. 
 <xref rid="T1" ref-type="table">Table 1</xref> identifies some key domains that could contribute to a core minimal dataset that informs clinical trial design for each priority pathogen.
</p>
